tirzepatide surpass 4 versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial Effects of tirzepatide versus insulin

If youre taking semaglutide (Wegovy): Stop taking it at least 2 months before a planned pregnancy If youre taking tirzepatide (Mounjaro): Stop taking it at least 1 month before a planned pregnancy

Semaglutide can be a weekly shot or a daily tablet, but the tracking job stays the same: remember the schedule, see when the medication feels strongest, log stomach symptoms before you forget them, and keep protein, water, fiber, and weight moving in the right direction

The first group had the lowest mean weight loss of 9.2% at 176 weeks

Tablets slip easily into gym bags for on-the-go dosing, whilst liquid capsules offer enhanced bioavailability